Status:
UNKNOWN
Ketonemia Through Menstrual Cycle
Lead Sponsor:
University of Pavia
Collaborating Sponsors:
IRCCS ISTITUTO NEUROLOGICO CASIMIRO MONDINO
Conditions:
Epilepsy
Drug Resistant Epilepsy
Eligibility:
FEMALE
12-35 years
Brief Summary
Ketogenic dietary therapies (KDTs) are well-established, safe, non-pharmacologic treatments used for children and adults with drug-resistant epilepsy and other neurological disorders. Ketone bodies le...
Eligibility Criteria
Inclusion
- Patients with drug resistant epilepsy or GLUT1DS undergoing KD from at least 3 months before inclusion to the study
- Patients who had menarche at least 3 months before inclusion to the study
- Absence of recognized endocrinologic problems/ disease
Exclusion
- Patients who experienced secondary amenorrhea
- Patients who have irregular menstrual cycle
- Pregnant patients
Key Trial Info
Start Date :
July 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2023
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT05234411
Start Date
July 1 2020
End Date
December 31 2023
Last Update
May 11 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Pavia
Pavia, Italy, 27100